Endoscopic off-pump aortic valve replacement: does the pericardial cuff improve the sutureless closure of left ventricular access? by Tozzi, P. et al.
www.elsevier.com/locate/ejcts
European Journal of Cardio-thoracic Surgery 31 (2007) 22—25Endoscopic off-pump aortic valve replacement: does the pericardial cuff
improve the sutureless closure of left ventricular access?§
Piergiorgio Tozzi a,*, Malgorzata Pawelec-Wojtalic b, Dorota Bukowska c,
Vassilios Argitis a, Ludwig K. von Segesser a
aCardiovascular Surgery Department, University of Lausanne CHUV, Rue du Bugnon 46, 1011 Lausanne, Switzerland
bDepartment of Pediatric Radiology, University of Medical Science, Poznan´, Poland
cDepartment of Veterinary Medicine, University of Agricolture, Poznan´, Poland
Received 3 April 2006; received in revised form 25 June 2006; accepted 4 July 2006; Available online 6 September 2006AbstractObjective: Off-pump trans left ventricular approach provides more precise deployment of stented aortic valve of any size with respect to the
endovascular replacement. One of the key steps of this procedure is the ventricle repair after catheter withdrawing. We designed an animal study
to compare the consistency of a sutureless repair of the left ventricle access using nitinol occluder with and without pericardial cuff on the
ventricular side. Methods: Material description: The Amplatz-nitinol occluder consists of two square heads squeezing ventricle wall in between
them, sealing the defect. To improve its sealing property, a pericardial patch was sutured to the ventricular head of the occluder. Animal study
setup: In adult pigs, a 30F sheath was inserted into the epigastric area through the cardiac apex, up to the left ventricle, simulating the approach
for off-pump aortic valve replacement. The sheath was then removed and the ventricle closed with standard occluder in half of the animals, and
cuffed occluder in the other half. Animals were followed-up for 3 h, collecting haemodynamics data and pericardial bleeding. Results:Device was
successfully deployed in 12 animals in less than 1 min. In the group where the standard occluder was used, bleeding during the deployment was
80  20 ml and after the deployment was 800  20 ml over 3 h. In the group where the cuffed occluder was used, bleeding during the deployment
was 85  20 ml and after the deployment was 100  5 ml over 3 h. In the cuffed group, bleeding was significantly lower than the standard group,
p-value being <0.001. Conclusions: The occluder is easy to use and the pericardial cuff dramatically increases its efficacy as demonstrated by a
significant reduction of blood loss. The cuffed occluder opens the way for endoscopic, off-pump, transventricular aortic valve replacement.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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In May1965, Davies et al. [1] first published the results of
12 patients suffering from aortic insufficiency, in which they
replaced the aortic valve without the assistance of the
extracorporeal circulation. They deployed a catheter-
mounted homograft aortic valve above the aortic valve
using an endovascular approach, and even if they demon-
strated the feasibility of the procedure, results were far from
the on-pump technique. Since then, many other authors have
modified and improved the endovascular approach for aortic
valve replacement (AVR) using stented biologic valves [2—4];
however, after 40 years, the endovascular approach for AVR
still presents several limitations that can be summarised as
follows: (1) the size of the valve is limited by the delivery§ Presented at the joint 19th Annual Meeting of the European Association for
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doi:10.1016/j.ejcts.2006.07.027sheath diameter, therefore, only small stented valves can be
implanted; (2) the precise positioning of the stented valve
onto the aortic annulus or in supra-annular position is
cumbersome because it is very difficult to properly drive long
and stiff catheters into the arterial tree. One potential
solution is the off-pump trans left ventricle approach (Fig. 1).
If the delivery sheath is inserted directly into the cardiac
apex, the so called transventricular approach, it would be
easier to handle the deployment process without any
limitation of the valve size. This concept has already been
demonstrated in our previous animal studies [5,6]. However,
the limiting factor of this procedure is the ventricle repair
after catheter withdrawing. The closure of the left ventricle
access is a challenging procedure even when the open chest
approach supported with extracorporeal circulation is used.
Moreover, there is a consistent risk of systemic air embolism
with catastrophic clinical consequences.
Recent developments of sutureless devices for endovas-
cular repair of interatrial septal defects could give us the right
tool to easily and safely close the ventricle access. Those
devices, however, have not been developed to deal withurgery. Published by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of the off-pump AVR with the left transven-
tricular approach.
Fig. 2. Front view of 12 mm Amplatz occluder with the pericardial cuff on the
ventricular side. The device is mounted into a 30F sheath to simulate the
deployment of 25 mm stented valve and its deployment is driven by semi rigid
wire.ventricular pressure and therefore, a technical improvement
is needed to ensure the haemostasis. Our hypothesis is that,
adding a pericardial cuff on the ventricular side of a standard
suturelessdevice for interatrial septaldefectscouldbeaneasy
and inexpensive method to safely close the ventricle access.
We designed an animal study to compare the consistency
of a sutureless repair of the left ventricle access using nitinol
occluder with and without pericardial cuff on the ventricular
side.Fig. 3. Videothoracoscopic view of pig’s heart. The 30F defect of the free wall
of the left ventricle has been repaired using an occluder. The guide wire that
holds the occluder is still connected to the nitinol device.2. Materials and methods
2.1. The occluder
Theoccluder12 mmAmplatz (AGA,GoldenValley,MN,USA)
is made of nickel—titanium alloy having pre determined
thermal memory shape. It consists of two square heads sque-
ezing ventricle wall in between them, sealing the ventricular
defect. A third element, a semi rigid guide wire, is secured to
the device for driving the deployment. This element is
unscrewed once the deployment is completed. The device is
mounted into a 30F sheath to simulate the deployment of
25 mm stented valve. The deployment starts into the left
ventriclewith the release of the endocardial square head. The
guide wire is gently pulled back until the square head is in
contact with ventricle wall. The second head is then released
pulling back the sheath and the guide wire is unscrewed.
To improve its sealing property, a pericardial patch
3 cm  3 cm was sutured with 6-O prolene to the ventricular
head of the occluder (Fig. 2).
The pericardial cuff does not affect the pushing/pulling
force required to displace the occluder inside the sheath.
2.2. Study design
An acute in vivo evaluation was performed in 12 adult pigs,
55  4.3 kg (range 43—56 kg) weigh, equipped with arterialpressure line in the right carotid artery and ECG. Under
general anaesthesia, left thoracoscopy was chosen to open
the pericardium. One 12 mm port was inserted into the 7th
intercostal space for the camera and two 5 mm ports were
inserted into the 11th and 5th spaces, respectively. A
pericardial window 4 cm  3 cm was then created to clearly
see cardiac apex. In six animals, a 3 cm  3 cm pericardial
patch was harvested and sutured onto the ventricular side of
the occluder. After heparin injection (100 U/kg), under ICUS
(Sequoia) inserted into the right femoral vein, and fluoro-
scopic control, we inserted the 30F sheath into the epigastric
area through the cardiac apex, up to the left ventricle,
simulating the approach for off-pump aortic valve replace-
ment. The sheath was then removed and the ventricle access
was closed with the standard occluder in six animals and with
the cuffed occluder in the other six animals (Fig. 3, Video 1).
Animals were then followed-up for 3 h, collecting haemody-
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Table 1
Haemodynamic data and blood loss volume during the occluder deployment to close the ventricle access used for transventricular aortic valve replacement
Baseline During deployment After deployment
Standard Cuffed Standard Cuffed Standard Cuffed
Mean arterial pressure 56  5 mmHg 48  5 mmHg 45  5 mmHg 53  5 mmHg 55  5 mmHg
ECG Sinus rhythm Ventricular extrasystole Sinus rhythm
Bleeding 80  20 ml 85  20 ml 800  20 ml/3 h 100  5 ml/3 h
p < 0.001
Two types of occluder were used: standard occluder and occluder cuffed with pericardium.namics data (heart rate, ECG, blood pressure, pO2, pCO2)
every 15 min. Pericardial bleeding was assessed using the
Smart Suction (Cardio Smart LLC, Fribourg, Switzerland) [7]
and the blood lost during the procedure was transfused to the
animal. Animals were then sacrificed and gross anatomy
examination of the heart carried out.
All the pigs received care in compliance with ‘the
Principles of Laboratory Animals’ formulated by the National
Society of Medical Research and ‘the Guide for the Care and
Use of Laboratory Animals’ prepared by the Institute of
Laboratory Animal Resources and published by the National
Institute of Health (NIH publication 85—23, revised 1985).
The protocol was approved by the Institutional Committee on
Animal Research.
Data were analysed with SPSS software (Statistical
Package for the Social Sciences). Paired t-tests were used.
Values were reported as mean  SD.3. Results
Device was successfully deployed in 12 animals in less than
1 min. ACT was above 200 s in all animals. No major
arrhythmias were detected. Monomorphic ventricular extra-
sistole was the most common arrhythmia. Blood pressure
during the deployment was 50  15 mmHg. In the group
where the standard occluder was used, bleeding during the
deployment was 80  20 ml and after the deployment was
800  20 ml over 3 h. In the group where the cuffed occluder
was used, bleeding during the deployment was 85  20 ml
and after the deployment was 100  5 ml over 3 h. In the
cuffed group, bleeding was significantly lower than the
standard group, p-value being <0.001.
Gross anatomy examination demonstrated the correct
positioning of the device. Detailed results are reported in
Table 1.4. Discussion
The transventricular approach for off-pump aortic valve
replacement with stented valves is considered the next
revolution in the cardiac surgery and its impact in aortic valve
disease treatment will be as important if not more, than that
of the angioplasty in coronary diseases.
One of the key steps of the transventricular approach is
the closure of the ventricular defect. Every cardiac surgeon
who has experimented knows that safely close a 30F hole of
the free wall of the left ventricle is a challenging procedure ifthere is no support of the extracorporeal circulation.
Moreover, since all the procedure is done percutaneously,
the closure of the left ventricle defect seems almost
impossible.
The aim of this study was to assess if it is possible to do
something that seems to be impossible simply by applying the
smart material technology.
The concept of using a two square heads nitinol device to
close cardiac wall defects has been extensively proved [8]
and nowadays the endovascular closure of patent foramen
ovale is considered a routine procedure. The 12 mm Amplatz
occluder has the same geometry as the one used for
interatrial septal defect closure, with the distance between
the two heads that increases up to 7 mm taking into account
the thickness of the ventricle wall. Fig. 3 shows how the
occluder looks like on the left ventricle surface.
However, the standard occluder caused 800 cc bleeding
over 3 h and is unsuitable for clinical use. But simply adding a
pericardial cuff on the ventricular side, we were able to
dramatically improve its capability to control the haemos-
tasis as demonstrated by a significant reduction of blood loss.
Before clinical application, however, more improvements are
necessary. One concern is of the ventricle thickness: in the
present configuration, the occluder does not work in case of
left ventricle hypertrophy because the epicardial head will
stay crimped into the ventricle wall. Finally, we should define
a back up strategy in case the device is lost during the
deployment as it happens during the endovascular closure of
patent foramen ovale.
This study, even with several limitations, has demon-
strated that the described nitinol device could be the
solution wewere looking for to complete the transventricular
approach for off-pump aortic valve replacement. The
occluder is easy to use and the procedure is feasible and
reproducible. We believe that this easy and costless
procedure opens the way for endoscopic, off-pump, trans-
ventricular aortic valve replacement.
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Appendix A. Conference discussion
Dr P. Kappetein (Rotterdam, The Netherlands): What do you think will
happen with the occluder at the long term, have you any idea? The pigs were
sacrificed quite early, but what do you think will happen in the long termwith it?
Dr Tozzi: I showed here just data from an acute study but we did also a
chronic study, and after 3 months the occluder is covered by a thin layer of scar
tissue, and the tissue around the occluder is also scarred. So if you want, in the
worst hypothesis, you can simulate this hole to a very small infarcted area. It issmall. Of course, you have to create a hole in the left ventricle. This is a small
price to pay.
Dr Kappetein: Have you seen in your long-term studies any bleeding
complications in the hours after the operation if your observations are longer
than what you described here?
Dr Tozzi: No, we didn’t experience that. You mean after the 3 h?
Dr Kappetein: Yes.
Dr Tozzi: No, because if it works, it will last for, we hope, longer years, but
if it does not work, you have traumatic bleeding, as I just showed you.
Dr C. Mestres (Barcelona, Spain): Just one comment. This is very old
business because the transventricular approach has been used for decades and
closed mitral commissurotomy and any other type of transventricular
approach. So if there is some scar tissue do you believe it may have some
potential for dilatation of the apical area, false aneurysms, these kinds of
things that have already been seen before?
Dr Tozzi: Could be, of course, but once again, this is a preliminary study
and I think we have, on the other side, lots of benefit to doing this procedure in
patients. We think we will be able to do this percutaneously. So it will be a
great improvement compared to what we have today.
Appendix B. Supplementary data
Supplementary data associated with this article can be found, in the online
version, at doi:10.1016/j.ejcts.2006.07.027.
